MARKET

ASMB

ASMB

Assembly
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.44
-0.56
-3.11%
After Hours: 17.44 0 0.01% 16:29 09/18 EDT
OPEN
18.23
PREV CLOSE
18.00
HIGH
18.30
LOW
16.97
VOLUME
919.63K
TURNOVER
--
52 WEEK HIGH
27.84
52 WEEK LOW
8.13
MARKET CAP
572.99M
P/E (TTM)
-6.9596
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average ASMB stock price target is 43.00 with a high estimate of 74.00 and a low estimate of 30.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ASMB
Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has discovered various core protein Allosteric Modulators (CpAMs), which are small molecules that directly target and allosterically modulate the HBV core (HBc) protein. Its Microbiome Program consists of an integrated platform that includes a strain identification and selection process, methods for strain isolation and growth under current good manufacturing practice conditions, and a delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal (GI) tract. The lead product candidate from this platform, AB-M101, is in development for the treatment of clostridium difficile-infections.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Assembly Biosciences Inc stock information, including NASDAQ:ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.